Sanofi Video Q&A: CFO Jérôme Contamine Comments on Q3 2011 Results

PARIS--(BUSINESS WIRE)-- Sanofi, a global and diversified healthcare leader, reports earnings for the third quarter of 2011. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on results and outlook.

Click to watch the video:
http://www.eurobusinessmedia.com/Sanofi-video-Q-A-CFO-Jerome-Contamine-comments-on-Q3-2011-results?utm_source=ceo-direct&utm_medium=bw

Topics covered in the interview include:

- Group Performance
- Emerging Markets
- Lantus®
- Genzyme
- Vaccines
- New Product Submissions
- 2011 Guidance

About Sanofi:

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Company website: www.sanofi.com



CONTACT:

Investor Relations:
Sébastien Martel, +33 1 53 77 45 45
[email protected]
or
Media Relations:
+33 1 53 77 45 02
[email protected],

KEYWORDS:   Europe  France

INDUSTRY KEYWORDS:   Health  Pharmaceutical  Diabetes  Veterinary

MEDIA:

Logo
 Logo

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.